AGP Picks
View all

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on September 2, 2026

Rientro a scuola, psicologa Claudia Matini: 'lo stress da rientro dei docenti non è solo stanchezza da vacanze finite'
Guangzhou Medical University Researchers Shed Light on How a Key Hormone Affects Fertility Treatment Outcomes
QCI Introduces Trip-Based Analysis for Host and Marketing Teams
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 août 2026
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
Patton and alfanar Partner™ to Accelerate Secure Digital Transformation of Saudi Power Infrastructure
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Major Drilling Announces Record Quarterly Revenue for Its First Quarter 2027
Zoom Appoints Former Oracle CFO Jeff Epstein to Board of Directors; Jonathan Chadwick to Retire
Five Reputable Smart Door Lock Manufacturers in China 2026: Empowering Intelligent Home Security
SONORO GOLD ANNOUNCES MANAGEMENT APPOINTMENTS
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Byrna Appoints Matt McBrady to Board of Directors
Supernus Pharmaceuticals to Participate in September Investor Conferences
Methode Electronics, Inc. Reports Fiscal 2027 First Quarter Financial Results
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
Matrix Announces Award for Front-End Engineering and Design on America First Refining Storage Tank Farm in Brownsville, Texas
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.